An Irish-based subsidiary of Allergan, the producers of Botox, recorded a pre-tax loss of over $252m (€189m) in 2010 as a result of legal settlements relating to certain therapeutic uses of Botox.

THE main Irish subsidiary of Allergan, the producers of Botox, last year increased its pre-tax profits by 80% to $87m (€59m).